CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Aurobindo Pharma Ltd.

NSE : AUROPHARMAEQ BSE : 524804 ISIN CODE : INE406A01037Industry : Pharmaceuticals

News

  • Aurobindo Pharma - Trading Window 24 Sep 2026 | 10:52 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations...more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 21 Sep 2026 | 16:05 | Dion Global

    Intimation of investor Analyst meet scheduled on 24.09.2026.more...
  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 21 Sep 2026 | 16:04 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Completion Of US FDA Inspection At Unit-II Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary O 15 Sep 2026 | 18:14 | Dion Global

    Submission of completion of US FDA inspection of Unit-II of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.more...
  • Aurobindo Pharma - General Updates 15 Sep 2026 | 18:12 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-II of Apitoria Pharma Private Limited a wholly owned...more...

  • Aurobindo Pharma gets USFDA final approval for Beclomethasone Inhalation Aerosol 15 Sep 2026 | 14:16 | Dion Global

    Aurobindo Pharma Limited has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Beclomethaso...more...
  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release 15 Sep 2026 | 13:11 | Dion Global

    Submission of Press Release that is being issued in connection with receipt of US FDA final approval for Beclomethasone Dipropionate HFA Inhalation A...more...

  • Aurobindo Pharma - Press Release 15 Sep 2026 | 13:04 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 15 2026 titled Aurobindo Pharma receives USFDA ...more...
  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Acquisition 12 Sep 2026 | 12:51 | Dion Global

    Intimation of subscription of 10 000 shares of USD 100 each of A1 Biochem USA Inc by A1 Biochem Labs (India) Private Limited a step down subsidiary o...more...

  • Aurobindo Pharma - Acquisition 12 Sep 2026 | 12:42 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Acquisitionmore...
  • Aurobindo Pharma - Completion Of US FDA Inspection At Unit-IV Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary O 11 Sep 2026 | 17:34 | Dion Global

    Intimation of completion of US FDA inspection of Unit-IV of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.more...

  • Aurobindo Pharma - General Updates 11 Sep 2026 | 17:31 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-IV of Apitoria Pharma Private Limited a who...more...
  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 11 Sep 2026 | 16:43 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 11 Sep 2026 | 16:42 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...
  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 11 Sep 2026 | 16:40 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep 2026 | 16:37 | Dion Global

    Intimation of investor / analyst meet scheduled on 22.09.2026.more...
  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep 2026 | 16:35 | Dion Global

    Intimation of investor / analyst meet scheduled on 21.09.2026.more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep 2026 | 16:31 | Dion Global

    Intimation of investor / analyst meet scheduled on 17.09.2026.more...
  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep 2026 | 13:17 | Dion Global

    Intimation of investor / analyst meet scheduled on 18.09.2026.more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep 2026 | 13:12 | Dion Global

    Intimation of Investor / analyst meet scheduled on 17.09.2026.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
More

Sensex72338.56-0.60%
NSE Index22609.6-0.74%
B500DIVL503357.4-0.84%
BSE 1000 10401.29-0.58%
BSE 100LCTMC8571.42-0.60%
BSE Auto 58123.15-0.96%
More

Commodity


Gold147394-2.63%
Silver223007-3.79%
Copper1422.5248.82%
Crude Oil888738.58%
Lead19645.83%
Mentha Oil1356.327.07%
Nickel1593107.72%
More

Currency


USD/INR95.8900 (-0.02%)
GBP/INR126.8300 (-0.15%)
EUR/INR109.1600 (-0.02%)
JPY/INR0.6100 (0.62%)
CAD/INR67.8200 (0.03%)
HKD/INR12.2200 (-0.07%)
More


Announcement Calendar

Previous monthSeptember 2026Next month
MonTueWedThuFriSatSun
311
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1234
567891011

Upcoming

BOARD MEETINGS
Company Name : LCC Projects
Date : 05-10-2026

More

Latest Videos

Watch More Videos